Bellevue Group Ag Revolution Medicines, Inc. Transaction History

Bellevue Group Ag

  • $5.02 Billion
  • Q4 2024

A detailed history of Bellevue Group Ag transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 4,386,900 shares of RVMD stock, worth $181 Million. This represents 3.82% of its overall portfolio holdings.

Number of Shares
4,386,900
Previous 4,871,360 9.95%
Holding current value
$181 Million
Previous $221 Million 13.07%
% of portfolio
3.82%
Previous 3.72%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$42.97 - $60.6 $20.8 Million - $29.4 Million
-484,460 Reduced 9.95%
4,386,900 $192 Million
Q3 2024

Nov 14, 2024
SELL
$36.92 - $47.94 $5.82 Million - $7.56 Million
-157,740 Reduced 3.14%
4,871,360 $221 Million
Q2 2024

Aug 14, 2024
SELL
$30.14 - $40.68 $1.34 Million - $1.81 Million
-44,500 Reduced 0.88%
5,029,100 $195 Million
Q1 2024

May 15, 2024
SELL
$26.56 - $33.55 $462,144 - $583,770
-17,400 Reduced 0.34%
5,073,600 $164 Million
Q4 2023

Feb 14, 2024
BUY
$18.35 - $34.12 $6.78 Million - $12.6 Million
369,500 Added 7.83%
5,091,000 $146 Million
Q3 2023

Nov 14, 2023
SELL
$25.17 - $35.05 $616,665 - $858,724
-24,500 Reduced 0.52%
4,721,500 $131 Million
Q2 2023

Aug 14, 2023
SELL
$20.28 - $27.0 $38,532 - $51,300
-1,900 Reduced 0.04%
4,746,000 $127 Million
Q1 2023

May 15, 2023
SELL
$20.76 - $30.09 $2.23 Million - $3.23 Million
-107,262 Reduced 2.21%
4,747,900 $103 Million
Q4 2022

Feb 14, 2023
BUY
$17.68 - $25.53 $3.09 Million - $4.47 Million
175,000 Added 3.74%
4,855,162 $116 Million
Q3 2022

Nov 14, 2022
BUY
$17.46 - $26.0 $22.6 Million - $33.7 Million
1,296,900 Added 38.33%
4,680,162 $92.3 Million
Q2 2022

Aug 11, 2022
BUY
$14.54 - $27.17 $1.06 Million - $1.97 Million
72,600 Added 2.19%
3,383,262 $65.9 Million
Q1 2022

May 13, 2022
SELL
$17.31 - $26.4 $2.76 Million - $4.21 Million
-159,500 Reduced 4.6%
3,310,662 $84.5 Million
Q4 2021

Feb 10, 2022
BUY
$24.35 - $33.7 $276,542 - $382,730
11,357 Added 0.33%
3,470,162 $87.3 Million
Q3 2021

Nov 12, 2021
BUY
$23.95 - $33.41 $38.4 Million - $53.6 Million
1,604,000 Added 86.48%
3,458,805 $95.2 Million
Q2 2021

Aug 12, 2021
BUY
$29.0 - $47.44 $22.9 Million - $37.4 Million
789,035 Added 74.03%
1,854,805 $58.9 Million
Q1 2021

May 12, 2021
BUY
$37.21 - $54.43 $38.2 Million - $55.8 Million
1,025,770 Added 2564.43%
1,065,770 $48.9 Million
Q4 2020

Feb 16, 2021
BUY
$30.19 - $45.49 $1.21 Million - $1.82 Million
40,000 New
40,000 $1.58 Million

Others Institutions Holding RVMD

# of Institutions
299
Shares Held
179M
Call Options Held
920K
Put Options Held
1.06M
View Full List

About Revolution Medicines, Inc.

RVMD Quotes by TradingView
  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.63B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email